期刊文献+

Optimal Threshold of Stimulated Serum Thyroglobulin Level for ^(18)F-FDG PET/CT imaging in Patients with Thyroid Cancer

Optimal Threshold of Stimulated Serum Thyroglobulin Level for ^(18)F-FDG PET/CT imaging in Patients with Thyroid Cancer
下载PDF
导出
摘要 This study was to explore the optimal threshold of thyroid-stimulating hormone(TSH)-stimulated serum thyroglobulin(s-Tg) for patients who were to receive18F-fluorodeoxyglucose(18F-FDG) PET/CT scan owing to clinical suspicion of differentiated thyroid cancer(DTC) recurrence but negative post-therapeutic 131I whole-body scan(131I-WBS). A total of 60 qualified patients underwent PET/CT scanning from October 2010 to July 2014. The receiver operating characteristic(ROC) curve analyses showed that s-Tg levels over 49 μg/L led to the highest diagnostic accuracy of PET/CT to detect recurrence, with a sensitivity of 89.5% and a specificity of 90.9%. Besides, bivariate correlation analysis showed positive correlation between s-Tg levels and the maximum standardized uptake values(SUVmax) of18F-FDG in patients with positive PET/CT scanning, suggesting a significant influence of TSH both on Tg release and uptake of18F-FDG. So, positive PET/CT imaging is expected when patients have negative 131I-WBS but s-Tg levels over 49 μg/L. This study was to explore the optimal threshold of thyroid-stimulating hormone(TSH)-stimulated serum thyroglobulin(s-Tg) for patients who were to receive ^(18)F-fluorodeoxyglucose(^(18)F-FDG) PET/CT scan owing to clinical suspicion of differentiated thyroid cancer(DTC) recurrence but negative post-therapeutic 131I whole-body scan(131I-WBS). A total of 60 qualified patients underwent PET/CT scanning from October 2010 to July 2014. The receiver operating characteristic(ROC) curve analyses showed that s-Tg levels over 49 μg/L led to the highest diagnostic accuracy of PET/CT to detect recurrence, with a sensitivity of 89.5% and a specificity of 90.9%. Besides, bivariate correlation analysis showed positive correlation between s-Tg levels and the maximum standardized uptake values(SUVmax) of ^(18)F-FDG in patients with positive PET/CT scanning, suggesting a significant influence of TSH both on Tg release and uptake of ^(18)F-FDG. So, positive PET/CT imaging is expected when patients have negative 131I-WBS but s-Tg levels over 49 μg/L.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2017年第3期429-432,共4页 华中科技大学学报(医学英德文版)
基金 supported by Shanghai Municipal Commission of Health and Family Planning of China(No.20134339)
关键词 18F-fluorodeoxyglucose(18F-FDG) positron emission tomography/computed tomography(PET/CT) differentiated thyroid cancer(DTC) post-therapeutic 131I whole-body scan(131I-WBS) serum thyroglobulin(Tg) thyroid-stimulating hormone(TSH) 18F-fluorodeoxyglucose(18F-FDG) positron emission tomography/computed tomography(PET/CT) differentiated thyroid cancer(DTC) post-therapeutic 131I whole-body scan(131I-WBS) serum thyroglobulin(Tg) thyroid-stimulating hormone(TSH)
  • 相关文献

参考文献1

二级参考文献7

  • 1Bertagna F, Bosio G, Biasiotto G, et al. F-18 FDG-PET/CT evalua- tion of patients with differentiated thyroid cancer with negative 1- 131 total body scan and high thyroglobulin level [ J]. Clin Nucl Med,2009,34 ( 11 ) : 756-761.
  • 2Hervouet T,Devillers A,Cuggia M,et al. Influence of rhTSH on 18 FDG uptake in a population of 42 patients with suspected recur- rence of differentiated thyroid carcinoma [ J ]. Med Nucl,2009,33 : 321-330.
  • 3Leboulleux S, Schroeder PR, Busaidy NL, et al. Assessment of the incremental value of recombinant thyrotropin stimulation before 2- [18F]-Fluoro-2-deoxy- D-glucose positron emission tomography! computed tomography imaging to localize residual differentiated thyroid cancer [ J ]. J Clin Endocrinol Metab, 2009, 94 (4) : 1310-1316.
  • 4Shammas A, Degirmenci B, Mountz JM, et al. 18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer[ J]. J Nucl Med ,2007,48 ( 2 ) :221-226.
  • 5Stokkel MP, Duchateau CS, Dragoiescu C. The value of FDG-PET in the follow- up of differentiated thyroid cancer: a review of the literature[ J]. Q j Nucl Med Mol Imaging,2006,50( 1 ) :78-87.
  • 6Kaneko K, Abe K, Baba S, et al. Detection of residual lymph node metastases in high-risk papillary thyroid cancer patients receiving adjuvant I131 therapy: the usefulness of F-18 FDG PET/CT[J]. Clin Nucl Med ,2010,35 ( 1 ) :6-11.
  • 7Ma C, Xie J, Lou Y, et al. The role of TSH for 18 F-FDG-PET in the diagnosis of recurrence and metastases of differentiated thyroid car- cinoma with elevated thyroglobulin and negative scan: a meta-anal- ysis [ J ]. Eur J Endocrino1,2010,163 (2) : 177-183.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部